Ocugen, Inc. (NASDAQ:OCGN) has seen 5,092,793 shares traded in the recent trading session. The company, currently valued at $23.91 Million, closed the recent trade at $0.2169 per share which meant it lost $0 on the day or -2.3% during that session. The OCGN stock price is -7922.13% off its 52-week high price of $17.4 and 21.62% above the 52-week low of $0.17. If we look at the company’s 10-day average daily trading volume, we find that it stood at 24.84 Million shares traded. The 3-month trading volume is 10.22 Million shares.
The consensus among analysts is that Ocugen, Inc. (OCGN) is an Overweight stock at the moment, with a recommendation rating of 2.5. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.03.
Ocugen, Inc. (NASDAQ:OCGN) trade information
Despite being -0.9% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Jun 24 when the OCGN stock price touched $0.281 or saw a rise of 21.35%. Year-to-date, Ocugen, Inc. shares have moved -57.5%, while the 5-day performance has seen it change -13.06%. Over the past 30 days, the shares of Ocugen, Inc. (NASDAQ:OCGN) have changed -28.71%. Short interest in the company has seen 164.05 Million shares shorted with days to cover at 16.05.
Wall Street analysts have a consensus price target for the stock at $0.98, which means that the shares’ value could jump 351.82% from current levels. The projected low price target is $0.7 while the price target rests at a high of $1.25. In that case, then, we find that the current price level is +476.3% off the targeted high while a plunge would see the stock lose 222.73% from current levels.
Ocugen, Inc. (OCGN) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +50.6% over the past 5 years. Earnings growth for 2020 is a modest +89.6% while over the next 5 years, the company’s earnings are expected to increase by 0%.
Ocugen, Inc. (NASDAQ:OCGN)’s Major holders
Insiders own 8.15% of the company shares, while shares held by institutions stand at 11.98% with a share float percentage of 13.04%. Investors are also buoyed by the number of investors in a company, with Ocugen, Inc. having a total of 17 institutions that hold shares in the company. The top two institutional holders are Renaissance Technologies, LLC with over 687.51 Thousand shares worth more than $193.26 Thousand. As of March 30, 2020, Renaissance Technologies, LLC held 0.92% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 645.99 Thousand shares as of March 30, 2020. The firm’s total holdings are worth over $181.59 Thousand and represent 0.87% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. As of March 30, 2020, the former fund manager holds about 0.44% shares in the company for having 329385 shares of worth $92.59 Thousand while later fund manager owns 194.49 Thousand shares of worth $54.67 Thousand as of March 30, 2020, which makes it owner of about 0.26% of company’s outstanding stock.